4/18
07:27 am
neo
NeoGenomics announces senior leadership promotions [Seeking Alpha]
Low
Report
NeoGenomics announces senior leadership promotions [Seeking Alpha]
4/18
07:23 am
neo
NeoGenomics Announces Senior Leadership Promotions [Yahoo! Finance]
Low
Report
NeoGenomics Announces Senior Leadership Promotions [Yahoo! Finance]
4/18
07:05 am
neo
NeoGenomics Announces Senior Leadership Promotions
Low
Report
NeoGenomics Announces Senior Leadership Promotions
4/9
07:00 am
neo
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
Medium
Report
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
3/27
08:33 am
neo
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting [Yahoo! Finance]
Low
Report
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting [Yahoo! Finance]
3/27
08:30 am
neo
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
Low
Report
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
3/20
01:21 pm
neo
All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy [Yahoo! Finance]
Low
Report
All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy [Yahoo! Finance]
3/20
07:12 am
neo
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
Medium
Report
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
3/20
07:00 am
neo
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
Medium
Report
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
3/1
07:05 am
neo
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
Low
Report
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
2/26
10:12 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Piper Sandler from $18.00 to $20.00. They now have an "overweight" rating on the stock.
Medium
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Piper Sandler from $18.00 to $20.00. They now have an "overweight" rating on the stock.
2/22
09:32 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $17.00 to $19.00. They now have a "buy" rating on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $17.00 to $19.00. They now have a "buy" rating on the stock.
2/22
06:10 am
neo
NeoGenomics Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]
Low
Report
NeoGenomics Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]
2/21
11:17 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its "outperform" rating re-affirmed by analysts at William Blair.
2/21
10:20 am
neo
NeoGenomics Stock Rises on Earnings Beat, Upbeat Guidance [MarketWatch]
Low
Report
NeoGenomics Stock Rises on Earnings Beat, Upbeat Guidance [MarketWatch]
2/21
10:11 am
neo
NeoGenomics shares jump after revenue forecast tops Street expectations [Seeking Alpha]
Low
Report
NeoGenomics shares jump after revenue forecast tops Street expectations [Seeking Alpha]
2/21
10:10 am
neo
NeoGenomics, Inc. (NASDAQ:NEO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
NeoGenomics, Inc. (NASDAQ:NEO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/21
08:00 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $21.00 to $24.00. They now have a "buy" rating on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $21.00 to $24.00. They now have a "buy" rating on the stock.
2/20
07:13 pm
neo
NeoGenomics (NEO) Q4 Earnings and Revenues Beat Estimates [Yahoo! Finance]
Low
Report
NeoGenomics (NEO) Q4 Earnings and Revenues Beat Estimates [Yahoo! Finance]
2/20
04:55 pm
neo
NeoGenomics Inc (NEO) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full Year 2023 [Yahoo! Finance]
Low
Report
NeoGenomics Inc (NEO) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full Year 2023 [Yahoo! Finance]
2/20
04:16 pm
neo
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
Medium
Report
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
2/20
04:05 pm
neo
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
Medium
Report
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
2/12
10:24 pm
neo
Cancer Clinical Decision Tools Market Poised for Robust Growth: Comprehensive Analysis Revealed in New Global Report [Yahoo! Finance]
Medium
Report
Cancer Clinical Decision Tools Market Poised for Robust Growth: Comprehensive Analysis Revealed in New Global Report [Yahoo! Finance]
2/4
10:30 am
neo
NeoGenomics: Progress, But A New Uncertainty [Seeking Alpha]
Medium
Report
NeoGenomics: Progress, But A New Uncertainty [Seeking Alpha]
2/1
07:24 am
neo
NeoGenomics Signs Working with Cancer Pledge in Support of Employees [Yahoo! Finance]
Low
Report
NeoGenomics Signs Working with Cancer Pledge in Support of Employees [Yahoo! Finance]